20072 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Liposomes; Processes for preparing; Proliposomes Post-loading, e.g. by ion or pH gradient
LIPOSOME COMPOSITIONS COMPRISING WEAK ACID DRUGS AND USES THEREOF
#2COMPOUND OR SALT THEREOF AND LIPID PARTICLES
#3RECONSTITUTED HIGH-DENSITY LIPOPROTEIN NANOPARTICLES COMPRISING CHOLESTEROL
#4COMPOSITIONS AND METHODS INVOLVING TRANSFORMING EXTRACELLULAR VESICLES
#5METHOD FOR ENHANCING THE EFFICIENCY OF DRUG LOADING INTO EXTRACELLULAR VESICLES AND MEDICINAL PRODUCTS THEREOF
#6NOVEL DUTOGLIPTIN FORMULATIONS AND THEIR PREPARATION
#7MESOPOROUS SILICA NANOPARTICLES WITH LIPID BILAYER COATING FOR CARGO DELIVERY
#8ENGINEERED HEMICHANNELS, ENGINEERED VESICLES, AND USES THEREOF
#9STABLE NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#10GEMCITABINE LIPOSOME PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF
#11Stabilizing Camptothecin Pharmaceutical Compositions
#12LIPOSOME COMPOSITIONS COMPRISING WEAK ACID DRUGS AND USES THEREOF
#13LIPOSOME ENCAPSULATED AFFINITY DRUG
#14LIPOSOME LOADING
#15OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF
#16OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF
#17URIC ACID LIPOSOMES
#18DUAL FUNCTION HYBRID NANOPARTICLES AND METHODS OF USING THE SAME TO TREAT DISEASES AND DISORDERS
#19COMPOUND OR SALT THEREOF AND LIPID PARTICLES
#20NOVEL LIPOPEPTIDE FORMULATION
#21Liposome compositions comprising weak acid drugs and uses thereof
#22ASSISTED LOADING OF HYDROPHOBIC MOLECULES INTO LIPOSOMES
#23Loading of Alginate Microspheres
#24Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#25LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR
#26METHODS OF PREPARING LIPID NANOPARTICLES
#27METHODS OF PREPARING LIPID NANOPARTICLES
#28LEVERAGING LIPID-PROTEIN INTERACTIONS TO ENGINEER SPATIAL ORGANIZATION IN CELL-FREE SYSTEMS
#29METHOD FOR PREPARATION OF LIPOSOMES
#30OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF
#31DEXAMETHASONE-LOADED MACROPHAGE-DERIVED MICROVESICLE AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF
#32Liposomes Useful for Drug Delivery
#33LIPOSOME FORMULATIONS FOR TREATMENT OF CANCERS AND DRUG RESISTANCE OF CANCERS
#34Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#35Stabilizing Camptothecin Pharmaceutical Compositions
#36RNA-LOADED NANOPARTICLES AND USE THEREOF FOR THE TREATMENT OF CANCER
#37NANOBOWL-SUPPORTED DRUG-LOADED LIPOSOME, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#38EXOSOME SYSTEMS, PRODUCTS AND METHODS
#39EXOSOME MIMICKING NANOVESICLES MAKING AND BIOLOGICAL USE
#40EXOSOME SYSTEMS, PRODUCTS AND METHODS
#41Preparation method of fatty acid liposome for VC encapsulation
#42Engineered nono-lyposomes for a targeted therapy of atherosclerosis and preparation process thereof
#43Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
#44PREPARING LIPOSOMES WITH HIGH DRUG LOADING CAPACITY AND THE USE THEREOF
#45Target-specific extracellular vesicles
#46A Continuous Processing System And Methods For Internal And External Modifications To Nanoparticles
#47Liposome loading
#48Liposomal compositions and methods of use
#49ENGINEERED HEMICHANNELS, ENGINEERED VESICLES, AND USES THEREOF
#50ALL-TRANS RETINOIC ACID LIPOSOME FORMULATION, AND PREPARATION AND USE THEREOF
#51PH-DEPENDENT VAGINAL COMPOSITIONS AND METHODS OF TREATMENT OF VAGINAL DISORDERS
#52COMPOSITIONS AND METHODS INVOLVING TRANSFORMING EXTRACELLULAR VESICLES
#53Stabilizing Camptothecin Pharmaceutical Compositions
#54TLR7/8 AGONISTS AND LIPOSOME COMPOSITIONS
#55Liposomes Useful for Drug Delivery
#56COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY
#57Liposome composition and method for producing the same
#58Liposome composition and method for producing same
#59LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR
#60BIOMOLECULAR COMPOSITES COMPRISING MODIFIED CELL GHOSTS
#61Compound or salt thereof and lipid particles
#62Liposome composition
#63Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
#64Lipid nanodisc formation by polymers having a pendant hydrophobic group
#65Stabilizing Camptothecin Pharmaceutical Compositions
#66Therapeutic Membrane Vesicles
#67Liposomal compositions and methods of use
#68STABLE LIPOSOMES FOR DRUG DELIVERY
#69Liposome composition and method for producing same
#70LIPOSOME COMPOSITIONS ENCAPSULATING MODIFIED CYCLODEXTRIN COMPLEXES AND USES THEREOF
#71Remote loading of sparingly water-soluble drugs into liposomes
#72Liposomal statin formulation
#73Stabilizing Camptothecin Pharmaceutical Compositions
#74LIPOSOMAL FORMULATIONS
#75Loading of Extracellular Vesicles through Imparting of Mechanical Shear
#76Mesoporous silica nanoparticles with a lipid bilayer coating for cargo delivery
#77Stable nanolipoprotein particles and related compositions methods and systems
#78Remote loading of sparingly water-soluble drugs into liposomes
#79Stabilizing Camptothecin Pharmaceutical Compositions
#80RGD PEPTIDE AND PENETRATING PEPTIDE R8 CO-MODIFIED ERGOSTEROL AND CISPLATIN ACTIVE DRUG-LOADING LIPOSOME
#81Compositions and methods for on-demand high-efficiency triggerable anesthesia
#82Pharmaceutical formulations of PEGylated liposomes and blood coagulation factors
#83Liposome compositions comprising weak acid drugs and uses thereof
#84Liposome formulation for delivery of Wnt signal pathway inhibitor
#85Esterification/saponification-based method for liposomal encapsulation of hydrophilic glucuronides
#86IMPROVED STABILITY OF LIPOSOME FORMULATIONS AND USES THEREOF
#87Microvesicles derived from nucleated, mammalian cells and use thereof
#88LIPOSOME INCLUDING TAXANE COMPOUND
#89VESICLE CONTAINING METALLIC NANOPARTICLE AND METHOD FOR PRODUCTION THEREOF
#90LIPOSOMES USEFUL FOR DRUG DELIVERY
#91MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES
#92Liposome loading
#93Artificial platelets for treating catastrophic bleeding
#94Liposomes useful for drug delivery
#95Liposome Compositions Encapsulating Modified Cyclodextrin Complexes and Uses Thereof
#96Combination liposomal pharmaceutical formulations
#97HIGH THROUGHPUT OPTIMIZATION OF CONTENT-LOADED NANOPARTICLES
#98Tubular and vesicular architectures formed from polymer-lipid blends and method for forming the same
#99Methods of treatment of vaginosis and vulvovaginitis
#100Liposomes useful for drug delivery
#101Methods for the Preparation of Liposomes Comprising Drugs
#102Compositions and methods for bile acid particles
#103PHARMACEUTICAL FORMULATIONS OF AND METHODS TO PREPARE CHELATING AGENTS FOR EFFICIENT METAL REMOVAL TREATMENT SYSTEMS
#104Dialyzer, liposome producing apparatus, and liposome producing method
#105REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES
#106Liposome composition and method for producing same
#107Liposome of irinotecan or irinotecan hydrochloride and preparation method thereof
#108Microfluidic liposome synthesis, purification and active drug loading
#109Liposomal drug encapsulation
#110IRINOTECAN HYDROCHLORIDE COMPOSITE PHOSPHOLIPID COMPOSITION, PREPARATION METHOD AND USE THEREOF
#111Thermosensitive nanoparticle formulations and method of making the same
#112Liposomes useful for drug delivery
#113Liposomes useful for drug delivery
#114STABLE LIPOSOMAL FORMULATIONS OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR TREATING CANCER
#115CLUSTOIDAL MULTILAMELLAR SOY LECITHIN PHOSPHOLIPID STRUCTURES FOR TRANSDERMAL, TRANSMUCOSAL, OR ORAL DELIVERY, IMPROVED INTESTINAL ABSORPTION, AND IMPROVED BIOAVAILABILITY OF NUTRIENTS
#116LIPOSOME COMPOSITION AND METHOD FOR PRODUCING SAME
#117Liposome composition and method for producing same
#118Liposome composition and method for producing same
#119PEPTIDE-CONJUGATED LIPOSOME
#120Methods for the preparation of liposomes
#121Liposome loading
#122Liposomes Useful for Drug Delivery
#123Remote loading of sparingly water-soluble drugs into liposomes
#124Nanosomal preparation of the complex formed by quercetin (or another flavonol, flavone or a derivative thereof) and 2-hydroxypropyl-beta-cyclodextrin for intravenous use in cerebral pathological conditions
#125Combination liposomal pharmaceutical formulations
#126Dual loaded liposomal pharmaceutical formulations
#127Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease
#128LIPOSOME ENCAPSULATED AFFINITY DRUG
#129Liposomes useful for drug delivery
#130Liposomes useful for drug delivery
#131Small Interfering RNA Delivery
#132Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles
#133Liposomes useful for drug delivery
#134Method for the preparation of liposome encapsulated vincristine for therapeutic use
#135Synergistic anti-cancer composition and a process for the preparation thereof
#136Lipidosome preparation, preparation method and application thereof
#137Long-lasting, controlled-release local anesthetic liposome preparation
#138Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same
#139Liposomes useful for drug delivery
#140Lipid formulations
#141Microfluidic liposome synthesis, purification and active drug loading
#142Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
#143STABLE LIPOSOMES FOR DRUG DELIVERY
#144Modified drugs for use in liposomal nanoparticles
#145LIPOSOMAL DRUG ENCAPSULATION
#146Liposomes co-encapsulating a bisphosphonate and an amphipathic agent
#147Acid stable liposomal compositions and methods for producing the same
#148REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES
#149REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES
#150METHODS FOR PREPARATION OF LIPID-ENCAPSULATED THERAPEUTIC AGENTS
#151AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS
#152Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
#153Methods for the preparation of liposomes comprising drugs
#154Liposome composition
#155MICROVESICLES DERIVED FROM NUCLEATED, MAMMALIAN CELLS AND USE THEREOF
#156Long-lasting controlled-release liposome composition and method for producing same
#157METHODS FOR PREPARATION OF LIPID-ENCAPSULATED THERAPEUTIC AGENTS
#158Liposomal formulations of lipophilic compounds
#159Method for preparing liposome-based constructs
#160Sustained release formulation of a non-steroidal anti-inflammatory drug
#161Sustained release formulation of a non-steroidal anti-inflammatory drug
#162LIPOSOME COMPOSITION AND PROCESS FOR PRODUCTION THEREOF
#163LIPOSOME COMPRISING COMBINATION OF CHLOROQUINE AND ADRIAMYCIN AND PREPARATION METHOD THEREOF
#164Sustained release formulation of a non-steroidal anti-inflammatory drug
#165Sustained release formulation of a non-steroidal anti-inflammatory drug
#166Sustained release formulation of a non-steroidal anti-inflammatory drug
#167Methods and compositions for delivery of active agents
#168ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING LOW CONCENTRATIONS OF PHOSPHATIDYLETHANOLAMINE
#169LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND PREPARATION METHOD THEREOF
#170METHODS FOR PREPARATION OF LIPID-ENCAPSULATED THERAPEUTIC AGENTS
#171Modified drugs for use in liposomal nanoparticles
#172Lipid formulation
#173Encapsulation of Plasmid DNA (Lipogenes) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome Complexes
#174MICROVESICLES DERIVED FROM NUCLEATED, MAMMALIAN CELLS AND USE THEREOF
#175Liposomes useful for drug delivery
#176Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy
#177Method of manufacture of liposome composition
#178SMALL INTERFERING RNA DELIVERY
#179Sustained release formulation of a non-steroidal anti-inflammatory drug
#180Solubilisation Method
#181Liposome Composition
#182Liposomal formulations of anthracycline agents and cytidine analogs
#183COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA
#184MATRIX METALLOPROTEINASE INHIBITOR
#185Tumor specific delivery of therapeutic agents via liposomase
#186LIPOSOME MANUFACTURING DEVICE
#187METHODS FOR PREPARATION OF LIPID-ENCAPSULATED THERAPEUTIC AGENTS
#188Modified drugs for use in liposomal nanoparticles
#189Materials and Methods for Making Improved Micelle Compositions
#190LIPOSOMAL CAMPTOTHECINS AND USES THEREOF
#191Methods for the preparation of liposomes comprising docetaxel
#192Methods for the Preparation of Liposomes Comprising Docetaxel
#193Methods for the preparation of liposomes
#194LIPID CARRIER COMPOSITIONS WITH ENHANCED BLOOD STABILITY
#195Lipid formulation
#196STEARICALLY STABILIZED UNILAMILAR VESICLES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF
#197Novel therapeutic delivery systems
#198Encapsulated peptide amphiphile nanostructures
#199LIPOSOMAL FORMULATIONS FOR TREATING CANCER
#200POLYPHENOL CONTAINING COMPOSITIONS
#201Liposome and method for producing the same
#202Method of drug loading in liposomes by gradient
#203Anthracycline derivatives
#204METHOD FOR PRODUCTION OF LIPOSOME PREPARATION
#205Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof
#206THERAPY FOR HUMAN CANCERS USING CISPLATIN AND OTHER DRUGS OR GENES ENCAPSULATED INTO LIPOSOMES
#207Liposomal formulations of hydrophobic lactone drugs in the presence of metal ions
#208Liposomal Formulations of Hydrophobic Lactone Drugs in the Presence of Metal Ions
#209LIPOSOMAL FORMULATIONS COMPRISING SECONDARY AND TERTIARY AMINES AND METHODS FOR PREPARING THEREOF
#210LIPOSOME COMPOSITIONS FOR IN VIVO ADMINISTRATION OF BORONIC ACID COMPOUNDS
#211Compositions and methods for treating lymphoma
#212Liposomal compositions for parenteral delivery of agents
#213Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
#214Method for preparing liposome formulations with a predefined release profile
#215Method for Preparing Lipid-Spacer-Reactive Functional Group-Peptide
#216Method and composition for solubilising a biologically active compound with low water solubilty
#217Method For Loading Multiple Agents Into Delivery Vehicles
#218Method for Preparing Lipid-Spacer-Reactive Functional Group-Peptide
#219Combination Therapy
#220LIPOSOMAL COMPOSITIONS FOR PARENTERAL DELIVERY OF AGENTS
#221Liposomal formulations of anthracycline agents and cytidine analogs
#222Anthracycline Derivatives
#223Loading of a camptothecin drug into colloidal nanoparticles
#224Regulation of cell proliferation and differentiation using topically applied peptides
#225Liposomes useful for drug delivery
#226Liposomes useful for drug delivery to the brain
#227Drug delivery systems for photodynamic therapy
#228Encapsulated arsenic drugs
#229Liposomal antineoplastic drugs and uses thereof
#230Methods for preparation of lipid-encapsulated therapeutic agents
#231Pharmaceutical compositions containing active agents having a lactone group and transition metal ions
#232Method for preparing liposome formulations with a predefined release profile
#233Phospholipid derivative
#234Liposomal camptothecins and uses thereof
#235Efficient liposomal encapsulation under mild conditions
#236Method for preparation of vesicles loaded with biological material and different uses thereof
#237Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
#238System for enhanced targeted delivery
#239Methods of preparing gaseous precursor-filled microspheres
#240Ultrasound imaging and treatment
#241Lipid carrier compositions with enhanced blood stability
#242Lipid carrier compositions and methods for improved drug retention
#243Liposome-entrapped topoisomerase inhibitors
#244Method for producing liposomal formulations of active ingredients